Study of Tisporin Eye Drops Group and Restasis Eye Drops Group After Treatment, Each Treatment Group Comparisons for Evaluation of Efficacy and Safety in Moderate to Severe Dry Eye Disease
Clinical trial NCT02229955 · COMPLETED
Trial details
- NCT number
- NCT02229955
- Sponsor
- Hanlim Pharm. Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-01
- Primary completion
- 2014-04-01
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.